Alex Boateng

Dr. Alex Boateng

Peptide Research Center, Chubu University, Kasugai, Aichi, Japan
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2021 in Cells
Verified
Journal Article
Open access
PDF file
YHYuria Hori
Yuria Hori
RTReiho Tsutsumi
Reiho Tsutsumi
KNKento Nasu
Kento Nasu
Alex BoatengAlex Boateng
Alex Boateng
YAYasuhiko Ashikari
Yasuhiko Ashikari
Takahiro SekiTakahiro Seki
Takahiro Seki
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. The inflammatory activation of microglia participates in dopaminergic neurodegeneration in PD. Therefore, chemicals that inhibit microglial activation are considered to have therapeutic potential for PD. Aromatic (ar)-turmerone is a main component of turmeric oil extracted from Curcuma longa and has anti-inflammatory activity in cultured microglia. The aims of the present study are (1) to investigate whether naturally occurring S-enantiomer of ar-turmerone (S-Tur) protects dopaminergic neurons in midbrain slice cultures and (2) to examine ar-turmerone analogs that have higher activities than S-Tur in inhibiting microglial activation and protecting dopaminergic neurons. R-enantiomer (R-Tur) and two analogs showed slightly higher anti-inflammatory effects in microglial BV2 cells. S- and R-Tur and these two analogs reversed dopaminergic neurodegeneration triggered by microglial activation in midbrain slice cultures. Unexpectedly, this neuroprotection was independent of the inhibition of microglial activation. Additionally, two analogs more potently inhibited dopaminergic neurodegeneration triggered by a neurotoxin, 1-methyl-4-phenylpyridinium, than S-Tur. Taken together, we identified two ar-turmerone analogs that directly and potently protected dopaminergic neurons. An investigation using dopaminergic neuronal precursor cells suggested the possible involvement of nuclear factor erythroid 2-related factor 2 in this neuroprotection.

27 December 2022 in ACS Omega
Verified
Journal Article
Open access
Alex BoatengAlex Boateng
Alex Boateng
MAMasayuki Amano
Masayuki Amano
MSMasaharu Sugiura
Masaharu Sugiura
A variety of unsaturated selenoesters (including phenolic ones) were produced in good to high yields and with high E/Z ratios using TiCl4-promoted aldol condensation between Se-phenyl selenoacetate and their respective aldehydes without aqueous workup. A representative phenolic unsaturated selenoester was applied to acylation of tyrosine methyl ester without protection of the phenolic hydroxy groups to furnish the corresponding amino acid conjugate. The conjugate reduction of the unsaturated selenoesters including phenolic ones and selenocoumarin with HSiEt3 was catalyzed by B(C6F5)3 to afford the corresponding saturated selenoesters in good to high yields. This method was also applicable to the reduction of a saturated selenoester to the corresponding O-silyl hemiselenoacetal in a high yield. Moreover, most acyclic unsaturated selenoesters were found to show good multiple antiviral activities against HIV-1, HBV, and SARS-CoV-2.

8 August 2024 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
PDF file
KMKensuke Motomura
Kensuke Motomura
EUErika Ueda
Erika Ueda
Alex BoatengAlex Boateng
Alex Boateng
MSMasaharu Sugiura
Masaharu Sugiura
KKKeiichi Kadoyama
Keiichi Kadoyama
Takahiro SekiTakahiro Seki
Takahiro Seki
Introduction: Aromatic (Ar)-turmerone is a bioactive component of turmeric oil obtained from Curcuma longa. We recently identified a novel analog (A2) of ar-turmerone that protects dopaminergic neurons from toxic stimuli by activating nuclear factor erythroid 2-related factor 2 (Nrf2). D-cysteine increases Nrf2, leading to the activation of chaperone-mediated autophagy (CMA), a pathway in the autophagy-lysosome protein degradation system, in primary cultured cerebellar Purkinje cells. In this study, we attempted to identify novel analogs of ar-turmerone that activate Nrf2 more potently and investigated whether these analogs activate CMA.Methods: Four novel analogs (A4–A7) from A2 were synthesized. We investigated the effects of A2 and novel 4 analogs on Nrf2 expression via immunoblotting and CMA activity via fluorescence observation.Results: Although all analogs, including A2, increased Nrf2 expression, only A4 activated CMA in SH-SY5Y cells. Additionally, A4-mediated CMA activation was not reversed by Nrf2 inhibition, indicating that A4 activated CMA via mechanisms other than Nrf2 activation. We focused on p38, which participates in CMA activation. Inhibition of p38 significantly prevented A4-mediated activation of CMA. Although all novel analogs significantly increased the phosphorylation of p38 6 h after drug treatment, only A4 significantly increased phosphorylation 24 h after treatment. Finally, we revealed that A4 protected SH-SY5Y cells from the cytotoxicity of rotenone, and that this protection was reversed by inhibiting p38.Conclusion: These findings suggest that the novel ar-turmerone analog, A4, activates CMA and protects SH-SY5Y cells through the persistent activation of p38.

17 March 2025 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
IRIsai Ramakrishna
Isai Ramakrishna
Alex BoatengAlex Boateng
Alex Boateng
THTomohiro Hattori
Tomohiro Hattori
KNKozue Nakagai
Kozue Nakagai
MKMasae Kawase
Masae Kawase
HYHisashi Yamamoto
Hisashi Yamamoto

1 September 2020 in Tetrahedron Letters
Verified
Journal Article
Closed access
Alex BoatengAlex Boateng
Alex Boateng
THTokifumi Harada
Tokifumi Harada
YAYasuhiko Ashikari
Yasuhiko Ashikari
MNMakoto Nakajima
Makoto Nakajima
MSMasaharu Sugiura
Masaharu Sugiura

4 September 2025 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
IRIsai Ramakrishna
Isai Ramakrishna
Alex BoatengAlex Boateng
Alex Boateng
THTomohiro Hattori
Tomohiro Hattori
HYHisashi Yamamoto
Hisashi Yamamoto
Conventional peptide synthesis involves multiple protection and deprotection steps, and typically relies on stoichiometric amounts of coupling reagents and additives. This makes the process cumbersome, and results in poor atom economy and hazardous waste generation. Therefore, direct peptide bond formation using unprotected amino acids is a promising alternative. However, this approach presents some challenges: 1) Solubility of unprotected amino acids in organic solvents; 2) Control of undesired side reactions; 3) Chemo-selective activation of the carboxylic acid group in the presence of an amine functionality; and 4) Epimerization. To address these challenges, we developed tris(2,2,2-trifluoroethoxy)silane [H-Si(OCH2CF3)3], a cost-effective and accessible coupling reagent. This single reagent efficiently synthesizes N-terminal free peptides from unprotected amino acids and amino acid tert-butyl esters, without the need for any additives. H-Si(OCH2CF3)3 enhances amino acid solubility through coordinating with both termini and plays a dual role, serving as a transient amine-protecting group and as a carboxylic acid activating or promoting reagent for peptide bond formation. This method is operationally simple and versatile, enabling the efficient synthesis of N-terminal free peptides from unprotected amino acids and amino acid tert-butyl esters, with good yields, high optical purity, and broad side-chain compatibility.